Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2026 09:00 ET | Source: Eliaz Therapeutics, Inc.

Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program

Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
June 11, 2026 17:51 ET | Source: Eliaz Therapeutics, Inc.

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis